Extended SARS-CoV-2 mRNA Vaccine Prime-Boost Intervals Enhances B Cell Immunity with Limited Impact on T Cells

Scientists compared in SARS-CoV-2 naïve donors B and T cell responses to two mRNA vaccine doses administered 3-4 versus 16 weeks apart.